Berlin, Germany

Martin Krueger

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2006-2014

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Martin Krueger

Introduction

Martin Krueger, based in Berlin, Germany, is a distinguished inventor recognized for his significant contributions in the field of pharmaceuticals. With a total of 14 patents to his name, Krueger has made substantial advancements through his innovative research and development efforts.

Latest Patents

Two of Martin Krueger's latest patents highlight his expertise and dedication to improving healthcare. The first patent concerns alkynylpyrimidines and their salts, which are pharmaceutical compositions aimed at addressing diseases related to dysregulated vascular growth. These compounds are particularly notable for their ability to interfere with Tie2 and VEGFR2 signaling pathways, offering potential treatments for various vascular growth disorders.

The second recent patent focuses on dihydropyridine derivatives that serve as effective protein kinase inhibitors. This innovation identifies novel compounds exhibiting protein tyrosine kinase inhibitory activity, which could be utilized for treating c-Met-mediated diseases or conditions, adding to the arsenal of therapeutic options available in modern medicine.

Career Highlights

Throughout his career, Martin Krueger has worked with reputable companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Bayer Schering Pharma AG. His experience with these leading firms has equipped him with valuable insights into drug development and the complexities of patenting innovative medical solutions.

Collaborations

Krueger has also collaborated with notable colleagues such as Andreas Huth and Martin Haberey. These partnerships have not only facilitated the advancement of his inventions but have significantly contributed to the collective knowledge in the fields of pharmacology and biotechnology.

Conclusion

Martin Krueger's relentless pursuit of innovation has led to meaningful advancements in pharmaceutical science. His patents showcase his commitment to addressing critical health issues and exemplify the vital role that inventors play in developing new treatment modalities. The impact of his work will likely resonate in the industry for years to come, as these innovations continue to pave the way for enhanced healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…